Blood Pressure Monitoring Devices Market Strengthens in Remote Monitoring

The global blood pressure monitoring devices market size was estimated at USD 3.8 billion in 2024 and is projected to reach USD 6.7 billion by 2030, expanding at a CAGR of 9.8% from 2025 to 2030. The increasing prevalence of hypertension, largely driven by changing lifestyles and rising obesity rates, remains a major factor fueling market growth throughout the forecast period.

Key Market Trends & Insights

  • North America dominated the global market with over 36.0% share in 2024.
  • The U.S. accounted for the largest share within the North American market.
  • By device type, the non-smart/traditional segment held the leading share of over 56.7% in 2024.
  • By end use, the hospital segment accounted for 51.2% share in 2024.

Market Size & Forecast

  • 2024 Market Size: USD 3.8 Billion
  • 2030 Projected Market Size: USD 6.7 Billion
  • CAGR (2025–2030): 9.8%
  • North America: Largest regional market in 2024

According to the World Health Organization (WHO), around 1.28 billion people worldwide suffered from hypertension as of 2019, positioning it as a leading cause of premature mortality. This growing patient pool, coupled with an aging population and rising lifestyle-related disorders, continues to elevate the demand for reliable blood pressure monitoring (BPM) devices.

Self-measured home blood pressure monitoring (SMBP) has gained significant importance, especially post-COVID-19, as global healthcare bodies—including the American Heart Association and NICE—recommend regular BP monitoring (twice daily for seven days). This widespread emphasis is further accelerating the adoption of home-use BP monitors.

Government-led health initiatives, public awareness campaigns, and large-scale BP monitoring programs also contribute to market expansion. For instance, the Integrated Health Model Initiative (IHMI) launched in 2019 by the American Medical Association introduced a data-driven model aimed at improving health outcomes, thereby supporting adoption.

Advancements such as mobile-compatible monitors, digital sphygmomanometers, portable and wearable BP devices, and mHealth platforms enhance patient compliance and provide real-time health data management. These technological improvements continue to play a vital role in driving growth across global markets.

Order a free sample PDF of the Blood Pressure Monitoring Devices Market Intelligence Study, published by Grand View Research.

Competitive Landscape

The global BPM devices market is highly competitive and price-sensitive. Leading companies are focusing on mergers, acquisitions, partnerships, and strategic collaborations to enhance product portfolios and maintain a strong market presence. Continuous investments in developing cost-effective, user-friendly, and technologically advanced devices are central to industry growth.

Key Companies in the Blood Pressure Monitoring Devices Market

  • Omron Healthcare
  • Welch Allyn, Inc.
  • A&D Medical Inc.
  • SunTech Medical, Inc.
  • American Diagnostics Corporation
  • Withings
  • Briggs Healthcare
  • GE Healthcare
  • Kaz Inc.
  • Microlife AG
  • Rossmax International Ltd.
  • GF Health Products Inc.
  • Spacelabs Healthcare Inc.
  • Philips Healthcare
  • Braun SE

Conclusion

The blood pressure monitoring devices market is poised for strong expansion driven by the rising global burden of hypertension, rapid advancements in digital health technologies, and increasing emphasis on home-based monitoring. Supportive government initiatives, growing healthcare awareness, and improved device accessibility further strengthen the market outlook through 2030. As innovation accelerates, the industry will continue evolving toward more connected, accurate, and user-friendly monitoring solutions.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Urodynamic Equipment and Consumables Market Forecast: Anticipating Future Innovations

  The global urodynamic equipment and consumables market size is expected to reach USD 449.2 million in 2030 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. This market is anticipated to grow at an unprecedented rate owing to growing geriatric population that exhibits greater vulnerability to urological dysfunctions. In addition, unprecedented upsurge in prevalence of bladder cancer poses high clinical urgency to adopt highly efficient diagnostics, which thereby broadens future growth prospects. In 2017, as per the American Cancer Society, bladder cancer accounted for 5.0% of all cancers in the U.S. The market is also driven by global increase in obesity. As per the Centers for Disease Control and Prevention, approximately 36.0% of adult population is obese. According to a research published in NCBI, obesity has increased the risk of developing various urological conditions, such as prostate cancer, nephrolithiasis, hypogonadism, and urinary tract infections. Furtherm...
Read more

Mobile Device Management Market Thrives with Growth in Cloud-Based Solutions

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...
Read more

U.S. Interventional Oncology Market Boosted by Aging Population

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...
Read more